Rhumbline Advisers Baxter International Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Baxter International Inc stock. As of the latest transaction made, Rhumbline Advisers holds 1,099,701 shares of BAX stock, worth $32.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,099,701

Previous 977,181 12.54%

Holding current value

$32.4 Million

Previous $32.7 Million 27.75%

% of portfolio

0.04%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$32.85 - $40.26 $4.02 Million - $4.93 Million	122,520 Added 12.54%	1,099,701 $41.8 Million
Q2 2024 Aug 01, 2024	SELL	$32.87 - $43.55 $473,393 - $627,207	-14,402 Reduced 1.45%	977,181 $32.7 Million
Q1 2024 May 09, 2024	SELL	$37.88 - $43.77 $550,623 - $636,240	-14,536 Reduced 1.44%	991,583 $42.4 Million
Q4 2023 Feb 08, 2024	BUY	$31.71 - $38.95 $951,395 - $1.17 Million	30,003 Added 3.07%	1,006,119 $38.9 Million
Q3 2023 Nov 09, 2023	SELL	$37.32 - $49.29 $1.09 Million - $1.44 Million	-29,297 Reduced 2.91%	976,116 $36.8 Million
Q2 2023 Aug 08, 2023	SELL	$39.98 - $47.68 $849,295 - $1.01 Million	-21,243 Reduced 2.07%	1,005,413 $45.8 Million
Q1 2023 May 11, 2023	BUY	$37.58 - $52.57 $1.44 Million - $2.02 Million	38,451 Added 3.89%	1,026,656 $41.6 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $1.59 Million - $1.85 Million	32,023 Added 3.35%	988,205 $50.4 Million
Q3 2022 Nov 10, 2022	SELL	$53.86 - $66.8 $1.01 Million - $1.25 Million	-18,681 Reduced 1.92%	956,182 $51.5 Million
Q2 2022 Aug 11, 2022	BUY	$63.83 - $80.0 $10.1 Million - $12.7 Million	158,284 Added 19.38%	974,863 $62.6 Million
Q1 2022 May 12, 2022	BUY	$76.85 - $89.45 $2.28 Million - $2.65 Million	29,670 Added 3.77%	816,579 $63.3 Million
Q4 2021 Feb 10, 2022	BUY	$74.57 - $87.19 $1.39 Million - $1.63 Million	18,669 Added 2.43%	786,909 $67.5 Million
Q3 2021 Nov 12, 2021	SELL	$73.77 - $83.61 $339,637 - $384,940	-4,604 Reduced 0.6%	768,240 $61.8 Million
Q2 2021 Aug 05, 2021	SELL	$80.5 - $88.01 $3.65 Million - $3.99 Million	-45,301 Reduced 5.54%	772,844 $62.2 Million
Q1 2021 May 06, 2021	SELL	$76.38 - $86.03 $3.97 Million - $4.48 Million	-52,024 Reduced 5.98%	818,145 $69 Million
Q4 2020 Feb 10, 2021	SELL	$75.39 - $82.36 $7.04 Million - $7.69 Million	-93,394 Reduced 9.69%	870,169 $69.8 Million
Q3 2020 Nov 12, 2020	BUY	$78.33 - $90.73 $820,663 - $950,578	10,477 Added 1.1%	963,563 $77.5 Million
Q2 2020 Aug 13, 2020	BUY	$78.66 - $94.14 $1.82 Million - $2.17 Million	23,080 Added 2.48%	953,086 $82.1 Million
Q1 2020 May 06, 2020	BUY	$71.57 - $93.3 $1.66 Million - $2.17 Million	23,244 Added 2.56%	930,006 $75.5 Million
Q4 2019 Feb 05, 2020	BUY	$76.7 - $88.45 $379,971 - $438,181	4,954 Added 0.55%	906,762 $75.8 Million
Q3 2019 Oct 23, 2019	BUY	$81.4 - $89.78 $826,047 - $911,087	10,148 Added 1.14%	901,808 $78.9 Million
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $2.1 Million - $2.36 Million	28,589 Added 3.31%	891,660 $73 Million
Q1 2019 May 01, 2019	SELL	$64.48 - $81.31 $539,117 - $679,832	-8,361 Reduced 0.96%	863,071 $70.2 Million
Q4 2018 Jan 31, 2019	BUY	$61.45 - $77.8 $1.35 Million - $1.71 Million	21,951 Added 2.58%	871,432 $57.4 Million
Q3 2018 Nov 07, 2018	SELL	$70.71 - $77.75 $720,322 - $792,039	-10,187 Reduced 1.18%	849,481 $65.5 Million
Q2 2018 Aug 06, 2018	SELL	$63.43 - $75.41 $1.14 Million - $1.36 Million	-18,038 Reduced 2.06%	859,668 $63.5 Million
Q1 2018 May 02, 2018	SELL	$62.56 - $72.26 $606,206 - $700,199	-9,690 Reduced 1.09%	877,706 $57.1 Million
Q4 2017 Feb 09, 2018	BUY	$61.45 - $66.05 $1.85 Million - $1.98 Million	30,049 Added 3.5%	887,396 $57.4 Million
Q3 2017 Nov 06, 2017	BUY	$59.5 - $64.61 $51 Million - $55.4 Million	857,347	857,347 $53.8 Million

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Baxter International Inc Transaction History